Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
08/2005
08/04/2005WO2005070923A1 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
08/04/2005WO2005070921A1 Polyethylene glycol conjugates of heterocycloalkyl carboxamido propanoic acids
08/04/2005WO2005070920A1 Amino-benzazoles as p2y1 receptor inhibitors
08/04/2005WO2005070916A1 Thiophene and furan compounds
08/04/2005WO2005070893A2 Azadecalin glucocorticoid receptor modulators
08/04/2005WO2005070891A2 Compounds and methods of use
08/04/2005WO2005070885A1 Bis bicyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropatic pain
08/04/2005WO2005070207A1 Modulators of the glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
08/04/2005WO2005070042A2 Novel chemical compounds
08/04/2005WO2005054179A3 Hydroxamic acid esters and pharmaceutical use thereof
08/04/2005WO2005018557A3 Substituted pyridinones
08/04/2005WO2004091485A3 Aminoquinoline compounds
08/04/2005WO2004007457A3 Substituted benzylamine derivatives and methods of use
08/04/2005US20050171188 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
08/04/2005US20050171187 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate
08/04/2005US20050171175 Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
08/04/2005US20050171173 Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors
08/04/2005US20050171172 platelet derived growth factor receptor; anticarcinogenic; leukemia; specific kinase inhibitors; accurate targeting with limited inhibition of other pathways; reduced toxicity
08/04/2005US20050171171 colony-stimulating factor receptor (c- FMS)-like tyrosine kinase 3; anticarcinogenic; leukemia;specific kinase inhibitors; accurate targeting with limited inhibition of other pathways; reduced toxicity
08/04/2005US20050171156 Prodrugs of potassium channel inhibitors
08/04/2005US20050171136 Modulators of the glucocorticoid receptor and method
08/04/2005US20050171103 Benzamide derivatives useful as histone deacetylase inhibitors
08/04/2005US20050171096 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
08/04/2005US20050171092 Chemical compounds
08/04/2005US20050171085 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
08/04/2005US20050169837 Coumarines useful as biomarkers
08/04/2005DE102004002758A1 Metallkomplexe als lichtabsorbierende Verbindungen in der Informationsschicht von optischen Datenträgern Metal complexes as light-absorbing compounds in the information layer of optical media
08/04/2005CA2554188A1 Polyethylene glycol conjugates of heterocycloalkyl carboxamido propanoic acids
08/04/2005CA2554138A1 Aryl substituted heterocycles, method for production and use thereof as medicaments
08/04/2005CA2553969A1 Vanilloid receptor ligands and their use in treatments
08/04/2005CA2553966A1 Vanilloid receptor ligands and their use in treatments
08/04/2005CA2553232A1 Substituted heterocyclic compounds and methods of use
08/04/2005CA2553010A1 Thiazole derivatives as a2b antagonists
08/04/2005CA2552419A1 Azadecalin glucocorticoid receptor modulators
08/03/2005EP1559714A1 Process for the preparation of 2-alkyl-3-aminothiophene derivatives and 3-aminothiophene derivatives
08/03/2005EP1559709A1 Heterocycle-containing carboxylic acid derivative and drug containing the same
08/03/2005EP1559428A1 Receptor regulator
08/03/2005EP1558609A2 Kinase inhibitors
08/03/2005EP1558608A1 Oxindole substituted piperazine derivatives
08/03/2005EP1558607A1 Compositions useful as inhibitors of rock and other protein kinases
08/03/2005EP1558599A2 Heteroarylpiperidine modulators of chemokine receptor activity
08/03/2005EP1558581A2 Triazolone and triazolethione derivatives
08/03/2005EP1558580A2 N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents
08/03/2005EP1558579A1 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials
08/03/2005EP1558576A2 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity
08/03/2005EP1558255A2 Dual binding site acetylcholinesterase inhibitors for the treatment of alzheimer's disease
08/03/2005EP1558250A1 Gamma-aminoamide modulators of chemokine receptor activity
08/03/2005EP1558243A2 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity
08/03/2005EP1284737B1 Water soluble prodrugs of azole compounds
08/03/2005EP1087948B1 2,4-diamino-1,3,5-triazine, method for the production and use of the same as herbicides and plant growth regulators
08/03/2005CN1649866A 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents
08/03/2005CN1649865A Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
08/03/2005CN1649864A Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
08/03/2005CN1649863A Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity
08/03/2005CN1649859A Substituted phenylacetamides and their use as glucokinase activators
08/03/2005CN1649855A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
08/03/2005CN1649853A Thiazolidinones compound, its preparing method and use as medicine
08/03/2005CN1649850A Cyclic compound, process for producing the same, and pest control agent
08/03/2005CN1649849A Tachykinin receptor antagonists
08/03/2005CN1649842A 2, 6-quinolinyl and 2, 6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors
08/03/2005CN1649831A Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
08/03/2005CN1649829A Novel florfenicol-type antibiotics
08/03/2005CN1649587A Use of epothilones in the treatment of brain diseases associated with proliferative processes
08/03/2005CN1649586A Heterocyclic amide derivatives for the treatment of diabetes and other diseases
08/03/2005CN1649498A 3-heteroaryl substituted 5-methyloxymethyl isoxazolines used as herbicides
08/03/2005CN1213045C Tyrosine kinase inhibitors
08/03/2005CN1213040C Serine protese inhibitors
08/03/2005CN1213038C Benzophenones as inhibitors of reverse transcriptase
08/03/2005CN1213036C Novel amide derivatives
08/03/2005CN1213035C 2,4-diamino-1,3,5-triazine, method for the production and use of the same as herbicides and plant growth regulators
08/03/2005CN1213026C Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
08/02/2005US6924376 Compounds, compositions and methods
08/02/2005US6924302 Nitrogen compounds such as 5-amino-3-[[4-(aminosulfonyl)phenyl]amino]-N-(2,6-difluorophenyl)-1H-1,2,4-triazole-1-carbothioamide, used as cyclin dependent and tyrosine kinase inhibitors, for prophylaxis of tumors
08/02/2005US6924301 Composition for treating or preventing arrhythmia
08/02/2005US6924297 Naphathalene derivatives which bind to the EP4 receptor
08/02/2005US6924295 Hetereocyclic amines such as 3-(5-(2-(2-(4-methylphenyl)-5-methyloxazol-4-yl)ethoxy)-1,2,3,4-tetrahydroquinolin-1-yl)propanoic acid ethyl ester, used as peroxisome proliferator activated receptor modulators; hyperlipemia; diabetis;
08/02/2005US6924293 Sulfonamide and sulfamide substituted imidazoquinolines
08/02/2005US6924287 Respiratory syncytial virus replication inhibitors
08/02/2005US6924284 PARP inhibitors
08/02/2005US6924278 Heterocyclic carboxy amines such as (2R)-1-[3,5-Bis(trifluoromethyl)benzoyl]-4-[4-((3S)-3-ethylmorpholino)-2-butynyl]-2-[(1H-indol-3-yl)methyl]piperazine, used as substance P and neurokinin antagonist for prophylaxis of diseases
08/02/2005US6924276 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
08/02/2005CA2243199C Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
08/02/2005CA2190087C Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic activities
08/02/2005CA2170020C Retroviral protease inhibiting compounds
07/2005
07/28/2005WO2005068460A1 Isothiazole dioxides as cxc- and cc- chemokine receptor ligands
07/28/2005WO2005068459A1 Metallic complexes used as light-absorbent compounds in the information layer of optical data carriers
07/28/2005WO2005068458A2 Five-membered heterocyclic compounds as inhibitors of src family protein kinase
07/28/2005WO2005068448A1 Sulfonamides antagonising n-type calcium channels
07/28/2005WO2005068444A2 Thiazole derivatives and use thereof
07/28/2005WO2005068443A1 Acrylonitriles and pest controlling agents
07/28/2005WO2005068433A1 Benzimidazole derivatives
07/28/2005WO2005067933A1 1-benzyl-5-piperazin-1-yl-3,4 dihydro-1h-quinazolin-2-one derivatives and the respective 1h-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzo(d) (1,3)oxazin-2-one derivatives as modulators of the 5-hydroxytryptamine receptor (5-ht) for the treatment of diseases of the central nervous system
07/28/2005WO2005067932A1 (3-oxo-3, 4-dihydro-quinoxalin-2-yl-amino) -benzamide derivatives and related compound as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
07/28/2005WO2005067644A2 Conjugated small molecules
07/28/2005WO2005048948A3 Urea derivatives as kinase modulators
07/28/2005WO2005037239A3 Use of a compound from the group of heterodiazoles or a salt of said compound, cosmetic or therapeutic formulation containing said compound or salt, said compound or salt as a therapeutic agent, and said salt
07/28/2005WO2005033102A3 Thiophene-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof
07/28/2005WO2004098498A3 Indole acetic acid derivatives and their use as pharmaceutical agents
07/28/2005WO2004060306A3 Anti-inflammatory medicaments
07/28/2005WO2002096905A8 Thiazole compounds useful as inhibitors of protein kinases
1 ... 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 ... 628